Debt-to-equity of RIGEL PHARMACEUTICALS INC from 30 Sep 2023 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: RIGEL PHARMACEUTICALS INC quarterly Debt-to-equity in % history and change rate from 30 Sep 2023 to 31 Dec 2025.
RIGEL PHARMACEUTICALS INC Debt-to-equity for the quarter ending 31 Dec 2025 was 87%.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

RIGEL PHARMACEUTICALS INC Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q4 2025	87%	+952%		31 Dec 2025
Q3 2025	256%	+844%		30 Sep 2025
Q2 2025	670%	+1169%		30 Jun 2025
Q1 2025	-2778%	-2282%	-460%	31 Mar 2025
Q4 2024	-866%	-346%	-67%	31 Dec 2024
Q3 2024	-588%	+13%	+2.2%	30 Sep 2024
Q2 2024	-499%			30 Jun 2024
Q1 2024	-496%			31 Mar 2024
Q4 2023	-519%			31 Dec 2023
Q3 2023	-601%			30 Sep 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.